Dr. Sulaiman Al Habib Reports SAR 1,165.95M Net Profit in the Six Months 2026
SULAIMAN ALHABIB 4013.SA | 0.00 |
On 2026-07-26 08:00:56 (Saudi Time), Dr. Sulaiman Al Habib Medical Services Group announced its Interim financial results for the six months ended on June 30, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 4,006.45 | 3,384.33 | 18.382 | 3,435.76 | 16.61 |
| Gross Profit (Loss) | 1,222.01 | 1,065.98 | 14.637 | 955.97 | 27.829 |
| Operational Profit (Loss) | 770.41 | 644.87 | 19.467 | 587.75 | 31.077 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 662.66 | 591.02 | 12.121 | 503.29 | 31.665 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 665.3 | 595.78 | 11.668 | 506.47 | 31.36 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 7,442.21 | 6,542.11 | 13.758 |
| Gross Profit (Loss) | 2,177.98 | 2,094.29 | 3.996 |
| Operational Profit (Loss) | 1,358.16 | 1,270.79 | 6.875 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 1,165.95 | 1,148.03 | 1.56 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 1,171.77 | 1,142.28 | 2.581 |
| Total Shareholders Equity (after Deducting Minority Equity) | 8,261.49 | 7,494.92 | 10.227 |
| Profit (Loss) per Share | 3.33 | 3.28 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
For H1 2026, Sales/Revenue increased by 13.758% YoY to SAR 7,442.21 million (vs. SAR 6,542.11 million in H1 2025), driven by growth across both the hospitals and pharmacies segments, supported by higher patient volumes, increased occupancy rates, and additional revenue from the HMG Solutions segment, as well as positive contributions from recently launched hospitals under the Group's strategic network expansion. Despite this strong top-line growth, net profit attributable to shareholders rose only modestly by 1.56% YoY to SAR 1,165.95 million (vs. SAR 1,148.03 million in H1 2025), as the significant increase in revenue was largely offset by fixed cost burdens associated with newly launched hospitals that are still in the operational ramp-up phase and have yet to reach optimal utilization levels. EBITDA for H1 2026 grew 13.22% to SAR 1,895.66 million at a margin of 25.47%, reflecting improved operating leverage, though net margin compression persisted due to the absorption of expansion-related fixed costs.
Quarter-on-Quarter Performance Drivers
QoQ revenue rose 16.61% to SAR 4,006.45 million in Q2 2026 from SAR 3,435.76 million in Q1 2026, primarily driven by the normalization of activity levels following seasonal factors that weighed on Q1, combined with continued growth in patient volumes and improved utilization across hospitals and pharmacies. Net profit surged 31.67% QoQ to SAR 662.66 million from SAR 503.29 million, supported by the revenue recovery and better operating leverage, though partially offset by ongoing fixed costs from recently launched hospitals still in the ramp-up phase.
Other Items
The external auditor issued an unmodified conclusion on the interim financial results for the six months ended June 30, 2026. No additional comments were noted in the auditor's report under any other matter, reservation, notice, disclaimer of opinion, or adverse opinion paragraphs. Total shareholders' equity (after deducting minority equity) stood at SAR 8,261.49 million as of the current period, compared to SAR 7,494.92 million in the same period of the prior year, representing an increase of 10.227%. Earnings per share for H1 2026 were SAR 3.33, compared to SAR 3.28 in H1 2025. No material risks, going concern uncertainties, debt covenant breaches, or accumulated losses were disclosed in the announcement.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=96969&anCat=1&cs=4013&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/8578_1601_2026-07-23_19-07-37_en.pdfImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.